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Vibrio cholerae is a Gram-negative enteropathogen causing potentially life-threatening
cholera disease outbreaks, for which the World Health Organization currently registers
2–4 million cases and ∼100.000 cholera-associated deaths annually worldwide.
Genomic Vibrio cholerae research revealed that the strains causing this ongoing
cholera pandemic are members of the El Tor biotype, which fully replaced the
Classical biotype that caused former cholera pandemics. While both of these
biotypes express the characteristic Cholera Toxin (CT), the El Tor biotype additionally
expresses the accessory toxins hemolysin (hlyA) and multifunctional auto-processing
repeat-in-toxin (MARTX). Previous studies demonstrated that the Classical biotype of
Vibrio cholerae triggers caspase-11-dependent non-canonical inflammasome activation
in macrophages following CT-mediated cytosolic delivery of LPS. In contrast to the
Classical biotype, we here show that El Tor Vibrio cholerae induces IL-1β maturation and
secretion in a caspase-11- and CT-independent manner. Instead, we show that El Tor
Vibrio cholerae engages the canonical Nlrp3 inflammasome for IL-1β secretion through
its accessory hlyA toxin. We further reveal the capacity of this enteropathogen to engage
the canonical Pyrin inflammasome as an accessory mechanism for IL-1β secretion
in conditions when the pro-inflammatory hlyA-Nlrp3 axis is blocked. Thus, we show
that the V. cholerae El Tor biotype does not trigger caspase-11 activation, but instead
triggers parallel Nlrp3- and Pyrin-dependent pathways toward canonical inflammasome
activation to induce IL-1β-mediated inflammatory responses. These findings further
unravel the complex inflammasome activating mechanisms that can be triggered when
macrophages face the full arsenal of El Tor Vibrio cholerae toxins, and as such increase
our understanding of host-pathogen interactions in the context of the Vibrio cholerae
biotype associated with the ongoing cholera pandemic.
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INTRODUCTION
Vibrio cholerae is a Gram-negative enteropathogen that caused
numerous cholera outbreaks in the past and remains a public
health threat also today, as illustrated by the current cholera
epidemic in Yemen that is among the largest outbreaks in the
last century (1). A recent genomic characterization of V. cholerae
strains collected in Yemen throughout 2016 and 2017 revealed
that all of these strains belonged to the El Tor biotype (1, 2).
Similar El Tor driven epidemics have affected regions in Africa
and Latin America in the past decades (3). Indeed, the El
Tor biotype is responsible for the ongoing seventh V. cholerae
pandemic for which the WHO registers 2–4 million cases and
∼100.000 cholera-associated deaths annually worldwide, and has
completely replaced the Classical biotype that caused former
pandemics (4, 5).
V. cholerae carries an arsenal of toxins contributing to
infection. Cholera toxin (CT) is the virulence factor responsible
for triggering the diarrheal manifestations of cholera disease. CT
accomplishes this through its A subunit (CTA) that activates
the adenylate cyclase in intestinal epithelial cells, which results
in a net secretion of chloride ions and water into the intestinal
lumen (6). While the molecular mechanisms by which they
contribute to cholera pathology is less clear, the accessory toxins
hemolysin (hlyA) and multifunctional auto-processing repeat-
in-toxin (MARTX) are characterized by their pore-forming
and cytoskeleton-disrupting cellular effects, respectively (7, 8).
Within the toxigenic V. cholerae O1 serogroup that caused
all seven cholera pandemics thus far, the Classical and El
Tor biotypes can be distinguished based on the absence or
the presence, respectively, of both hlyA and MARTX (9–14).
However, compared to the Classical biotype, it is not clear how
the additional expression of the accessory hlyA and MARTX
toxins alters host innate immune responses to the V. cholerae El
Tor biotype.
Inflammasomes represent a family of signaling complexes
in which detection of specific bacterial components or cellular
danger signals through various cytosolic receptors leads to
activation of the catalytic caspase-1 component that mediates
maturation and secretion of the Interleukin (IL)-1β and
IL-18 pro-inflammatory cytokines (15). For instance, both
Nlrc4 and Nlrp3 inflammasomes contribute to caspase-1
activation upon infection with Salmonella Typhimurium (16–
18). In contrast, Clostridium difficile uses its cytotoxins
to inactivate host Rho GTPases, which in turn triggers
the Pyrin inflammasome to activate caspase-1 (19). The
above examples constitute so-called canonical inflammasome
pathways that rely solely on caspase-1 activity to mediate
their innate immunity effects. However, several Gram-negative
enteropathogens such as Citrobacter rodentium and Escherichia
coli were shown to trigger a non-canonical inflammasome
pathway that requires additional caspase-11 activity (20,
21). The non-canonical inflammasome pathway is initiated
upon recognition of cytosolic Lipopolysaccharide (LPS) by
caspase-11, which triggers inflammasome activation in an
Nlrp3-dependent manner (22). Akin to this mechanism, the
non-enzymatic CT subunit B (CTB) of V. cholerae binds
to GM1 gangliosides on the host cellular surface and as
such can act as a carrier that facilitates cytosolic entry of
LPS (20). Consistent with the mechanism of non-canonical
inflammasome activation, challenging macrophages with a
combination of CTB and LPS, as well as with live V.
cholerae, indeed resulted in a caspase-11- and Nlrp3-dependent
manner of IL-1β secretion (20, 21). However, this non-
canonical pathway of inflammasome activation upon V. cholerae
infection was established using the Classical biotype of the
bacterium (20). Given that this biotype harbors deletions in
the genes encoding hlyA and MARTX (9–14), it remains to
be elucidated whether and how the toxins expressed by the
El Tor biotype impact on the mode of V. cholerae induced
inflammasome activation.
In contrast to reports based on the Classical biotype, we
here show that the CT- and caspase-11-dependent non-canonical
pathway is redundant for triggering inflammasome responses
upon infection with El Tor V. cholerae. Instead, the latter biotype
predominantly activates the canonical Nlrp3 inflammasome
through its hlyA toxin. Intriguingly, in conditions of impaired
Nlrp3 inflammasome activation, El Tor V. cholerae initiated
a backup pathway toward IL-1β maturation and secretion by
triggering the canonical Pyrin inflammasome in a CT- and
hlyA-independent manner. Altogether, our study shows that
host inflammasome responses to the El Tor biotype V. cholerae
are independent of CT, but instead are triggered by concerted
actions of other toxins that activate distinct canonical Nlrp3 and
Pyrin inflammasomes.
MATERIALS AND METHODS
Ethics Statement
All animal experiments were performed according to
institutionally approved protocols according to national
(Belgian Laws 14/08/1986 and 22/12/2003, Belgian Royal
Decree 06/04/2010) and European (EU Directives 2010/63/EU,
86/609/EEG) animal regulations. Animal protocols were
reviewed and approved by the Ethical Committee Animal
Experimentation—Ghent University—Faculty of Medicine and
Health Sciences (permit number LA1400536) with approval
ID ECD 14/40. All necessary efforts were made to minimize
suffering of the animals.
Mice
The caspase1/11−/− (23), caspase11−/− (24), ASC−/− (25),
Nlrp3−/− (24), Nlrc4−/− (25), Aim2−/− (26), and Pyrin−/− (27)
mice used in this study, either generated on C57BL/6 background
or backcrossed at least ten generations to C57BL/6J background,
have been described previously. Wild-type (WT) C57BL/6J mice
were originally obtained fromCharles River but were—as all mice
used in this study—bred and housed in individually ventilated
cages (IVC) in the Specific Pathogen Free facility at Ghent
University in a 12-h light-12-h dark cycle and were fed autoclaved
standard rodent feed (Ssniff, Soest, Germany) at libitum with free
access to drinking water.
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Bacterial Strains
The V. cholerae El Tor N16961 strain, originally isolated from
a cholera patient in Bangladesh, was obtained from Pasteur
Institute, Paris, France. The isogenic JBK70 (1ctxAB) and
CvD104 (1ctxAB/hlyA) mutants of this V. cholerae El Tor
N16961 strain were generated and kindly provided by James B.
Kaper (University of Maryland, Baltimore, MD) (28). All the
bacterial strains used for this study were grown in Luria-Bertani
(LB) broth at 37◦C while shaking. When indicated, El Tor V.
cholerae strains were grown under AKI conditions for boosting
CT production as described (29, 30).
Cholera Toxin Detection
Secretion of Cholera Toxin in culturemediumwas detected using
a GM1-ELISA method. In short, microwell plates were coated
with GM1 ganglioside (Sigma Aldrich) overnight at RT. Plates
were washed with 0.05% Tween 20 in PBS buffer and blocked
with 1% BSA in PBS for 30min at RT. Supernatants from V.
cholerae cultures grown to an identical optical density (OD) for
ensuring equal numbers of bacteria were added in duplicate (100
µl/well) and incubated for 1 h at 37◦C. For a standard curve,
selected wells were supplied with purified Cholera Toxin (Enzo
life sciences) in PBS with 0.1% BSA in a concentration range
from 0.1 to 20 ng/ml. Immobilized CT was detected with 100
µl/well Anti-Cholera Toxin subunit B goat primary antibody
(Merck Millipore), followed by rabbit anti-goat horseradish
peroxidase conjugate (Jackson ImmunoResearch). Results were
visualized upon addition of p-nitrophenyl phosphate buffer
(Sigma-Aldrich) for conjugate activation and the resulting OD
at 405 nm was measured by spectrophotometry.
V. cholerae Infection of Bone
Marrow-Derived Macrophages (BMDMs)
Murine bone marrow cells were differentiated in Iscove’s
Modified Dulbecco’s Medium (IMDM) supplemented with 30%
L929 cell conditioned medium, 10% heat-inactivated fetal bovine
serum (FBS), 1% non-essential amino acids and 1% penicillin-
streptomycin. The cells were incubated for 6 days at 37◦C and
5% CO2. BMDMs were seeded and incubated overnight at 37
◦C.
Next BMDMs were primed with 500 ng/ml ultrapure LPS from
Salmonella minnesota (InvivoGen) for 3 h. Subsequently, the
LPS-containing medium was aspirated and the BMDMs were
infected with V. cholerae at multiplicity of infection (MOI) 50
in Iscove’s Modified Dulbecco’s Medium (IMDM) supplemented
with 10% fetal bovine serum (FBS) and 1% non-essential amino
acids. When indicated, cells were additionally pre-treated with
10µM of MCC950 (Sigma) for 30min before infection. After
infection, plates were centrifuged at 600xg for 10min to ensure
synchronization of the stage of infection. After incubating for
2 h at 37◦C and 5% CO2, gentamicin (50µg/ml) was added to
kill remaining extracellular bacteria, after which the cells were
incubated at 37◦C and 5% CO2 for 18 h. At 24 h post infection
cell culture supernatants were collected and used for cytokine
analyses while supernatant containing cell lysates were used for
Western blotting analysis.
Cytokine Measurements
IL-1β and TNF cytokine secretion levels were analyzed from
supernatants of cultured BMDMs by magnetic bead-based
multiplex ELISA using the Bio-Rad Luminex technology
according to the manufacturer’s protocol. Data representation
and analysis was performed in GraphPad Prism 6.0 software.
Immunoblotting
Cells and culture supernatants were incubated in cell lysis buffer
(20mM Tris HCl (pH 7.4), 200mM NaCl, 1% Nonidet P-40) for
10min on ice followed by denaturation by boiling in Laemmli
buffer for 10min. Protein samples were resolved by SDS-
PAGE electrophoresis and then transferred to polyvinylidene
fluoride (PVDF) membranes by semi-dry blotting. The PVDF
membrane blocking, antibody incubation, and washing steps
were performed using PBS containing 0.05% Tween 20 (v/v)
together with 3% (w/v) non-fat dry milk. The incubation
of the membranes with primary antibody was performed
overnight at 4◦C and the primary antibodies used in this study
included: caspase-1 (AG-20B-0042-C100, 1:1,000, Adipogen),
IL-1β (GTX74034, 1:3,000, GeneTex) and γ-Tubulin (T6557-
100UL, 1:1,000, Sigma Aldrich). HRP-conjugated secondary anti-
mouse and anti-rabbit antibodies (111-035-144 and 115-035-
146; 1:5,000, Jackson ImmunoResearch Laboratories), followed
by ECL (Thermo Scientific) incubation were used for signal
detection and visualization.
Lactate Dehydrogenase (LDH) Assay
Lytic cell death was evaluated by detection of LDH released from
cultured BMDMs in the cell culture supernatant by LDH assay
(Promega) according to manufacturer’s instructions. The data
was plotted as percentage of total cell death using GraphPad
Prism 7 software.
Microscopy
BMDMs were infected with indicated V. cholerae genotypes at
MOI50 and incubated for 2 h prior visualization with bright field
microscopy. Images were taken at 400×magnification.
RESULTS
El Tor V. cholerae Activates the
Caspase-11 Independent Canonical
Pathway of Inflammasome Activation
The Classical biotype of V. cholerae was reported to activate the
non-canonical inflammasome pathway that was dependent on
the presence of caspase-11 (20). In order to characterize themode
of inflammasome activation triggered by the El Tor V. cholerae
biotype, primary bone marrow-derived macrophages (BMDMs)
from caspase-1/11−/− or caspase-11−/− mice were infected with
the V. cholerae El Tor biotype N16961 strain (hereafter referred
to as V. cholerae). In contrast to WT macrophages that secreted
large amounts of IL-1β in the cell culture supernatant upon V.
cholerae infection, caspase-1/11−/− BMDMs displayed only little
IL-1β secretion (Figure 1A). As the inflammasome-independent
cytokine TNF was secreted normally from V. cholerae infected
caspase-1/11−/− cells (Figure 1B), this observation confirmed
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FIGURE 1 | Caspase-11 independent canonical inflammasome activation upon El Tor V. cholerae infection. (A–D) LPS-primed BMDMs from WT, caspase-11−/− and
caspase-1/11−/− mice were untreated (control) or infected with V. cholerae (V.c.) at MOI50. At 24 h post infection (A) cell culture supernatants were analyzed for
secreted IL-1β and (B) TNF by ELISA, and (C) cell lysates were immunoblotted for IL-1β and caspase-1 maturation. (D) Cell death was determined 6 and 24 h post
infection by LDH release assay. (E) ELISA for CT expression in V. cholerae culture supernatants cultured with LB or under AKI growth conditions. (F) LPS-primed
BMDMs from WT, caspase-11−/− and caspase-1/11−/− mice were untreated (control) or infected with V. cholerae at MOI50 grown under indicated LB or AKI culture
conditions. At 24 h post infection culture supernatants were analyzed for secreted IL-1β by ELISA. Data shown in (A,B,D) are means ± SD of triplicate wells from a
representative experiment out of three independent experiments. Data shown in (C) are representative for three independent experiments. Data shown in (E,F) are
means ± SD of triplicate wells from a single experiment.
that V. cholerae infection induces a specific inflammasome-
driven IL-1β response in primary macrophages. Surprisingly,
V. cholerae infection induced similar IL-1β secretion levels in
caspase-11-deficient cells compared to WT cells (Figure 1A).
Moreover, western blotting analysis showed decreased processing
of pro-IL-1β to its mature IL-1β form in caspase-1/11−/− but
not in caspase-11−/− macrophages upon V. cholerae infection
(Figure 1C). In addition, proteolytic caspase-1 processing upon
V. cholerae infection was intact in the absence of caspase-11
(Figure 1C). Finally, we evaluated lytic cell death by measuring
the levels of intracellular LDH released into the culture medium
at different time points post infection. Notably, while at 6 h post
infection cytotoxicity was slightly reduced in caspase-1/11−/−
but not in caspase-11−/− macrophages, V. cholerae infection
was equally cytotoxic to all genotypes at 24 h post infection
(Figure 1D). This delay in cytotoxicity in caspase-1/11−/−
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but not in caspase-11−/− macrophages indicated a direct
link between caspase-1-dependent (but caspase-11-independent)
inflammasome activity and lytic cell death during early stages
of infection, whereas additional inflammasome-independent
pathways drive lytic cell death during later stages of V. cholerae
infection. Together, these observations indicated that the El Tor
V. cholerae biotype drives the caspase-1 dependent canonical
pathway of inflammasome activation, rather than the non-
canonical caspase-11 dependent pathway.
Because El Tor V. cholerae are known for their moderate
CT production, we next aimed to boost CT expression in order
to firmly establish the potential contribution of CT-mediated
caspase-11 activation in inflammasome responses triggered by
this biotype. Indeed, when cultured in LB medium under
standard aerobic growth conditions, the N16961 El Tor strain
did not secrete detectable levels of CT in the culture medium
(Figure 1E), raising the possibility that the observed caspase-
11 redundancy in inflammasome activation could stem from
insufficient CT expression levels. We therefore cultured the
N16961 El Tor strain in specific micro-aerobic growth conditions
using AKI medium (29), which induced significant CT secretion
in the medium (Figure 1E). Nevertheless, using this El Tor
V. cholerae strain grown under these CT-boosting culturing
conditions, we obtained similar results showing activation of
the caspase-11-independent canonical inflammasome pathway.
Indeed, IL-1β secretion was reduced in caspase-1/11−/− but
not in caspase-11−/− macrophages infected by V. cholerae
grown in AKI conditions (Figure 1F). As such, our results
demonstrated that El Tor V. cholerae engages the canonical
caspase-1-dependent but caspase-11-independent pathway of
inflammasome activation leading to maturation and secretion
of IL-1β.
Hemolysin Is the Main Driver of Canonical
Inflammasome Activation Upon El Tor
V. cholerae Infection
Our above observations showed that caspase-11 did not
contribute to IL-1β secretion upon infection with El Tor
V. cholerae, suggesting that CT-mediated cytosolic entry of
LPS does not play a role in inflammasome activation by
this biotype. Therefore, we next used bacterial mutants to
examine more directly the role of CT in V. cholerae induced
IL-1β secretion, as well as to investigate which other toxins
of this enteropathogen triggered the canonical inflammasome
pathway. For this purpose, an El Tor V. cholerae N16961 strain
isogenic mutant deleted for the genes encoding CTA and CTB
(1ctxAB) was used, as well as this 1ctxAB mutant harboring
an additional deletion of the hemolysin A gene (1ctxAB/hlyA)
(28). Upon challenging WT BMDMs with these different V.
cholerae mutants, the characteristic rounding phenotype of
macrophages was observed upon infection with all bacterial
genotypes alike, confirming successful infection (Figure 2A).
Additionally, similar levels of secreted TNF upon infection
with the respective mutants (Figure 2B) provided further proof
for equal macrophage infectivity of these different V. cholerae
strains. Interestingly, the V. cholerae 1ctxAB mutant triggered
similar levels of IL-1β release as the WT pathogen (Figure 2C),
thereby confirming the redundancy of CT-mediated caspase-
11 activation in inflammasome responses to this bacterium.
In contrast, the double 1ctxAB/hlyA mutant displayed a
clear reduction in IL-1β secretion compared to WT bacteria
(Figure 2C), indicating a central role for hemolysin during
canonical inflammasome activation in El TorV. cholerae infected
BMDMs. Moreover, analysis of macrophage cell death upon
infection with the different V. cholerae genotypes revealed a
hemolysin dependency at an early but not at a late time
point of infection (Figure 2D). Due to the similarity with the
aforementioned caspase-1-dependent cell death kinetics upon
V. cholerae infection, this observation suggested that during
early stages of infection El Tor V. cholerae hemolysin drives
canonical inflammasome-dependent macrophage cell death.
Consistently, western blotting analysis of caspase-1 and IL-1β
maturation further validated El Tor hemolysin as the main driver
of canonical inflammasome activation (Figure 2E). Altogether,
although some residual proteolytic maturation of IL-1β could
be observed in 1ctxAB/hlyA infected cells (Figure 2E), thus
pointing to additional inflammasome activating mechanisms in
the absence of CT and hemolysin, our data indicated that El
Tor V. cholerae activated the canonical inflammasome pathway
predominantly through hemolysin.
El Tor V. cholerae Predominantly Activates
the Canonical Nlrp3 Inflammasome
To further characterize the nature of canonical inflammasome
activation triggered by El Tor V. cholerae infection, we
next infected BMDMs derived from mice that were either
deficient for the general inflammasome adaptor protein ASC
or deficient for different inflammasome triggering receptors.
As expected, since ASC is essential for IL-1β secretion
downstream of all known inflammasomes, deletion of ASC
disabled V. cholerae to induce IL-1β secretion from macrophages
(Figure 3A). However, comparing IL-1β secretion from V.
cholerae infected WT, Nlrp3−/−, Nlrc4−/−, and Aim2−/−
BMDMs revealed a specific role for the Nlrp3 inflammasome
in this response. Indeed, only Nlrp3−/− macrophages displayed
a reduction in IL-1β secretion upon V. cholerae infection
(Figure 3A), while the inflammasome-independent cytokine
TNF was induced normally in the absence of Nlrp3 (Figure 3B).
These central roles for both ASC and Nlrp3 in inflammasome
responses upon El Tor infection were further confirmed by
western blotting analysis showing decreased processing of
both caspase-1 and IL-1β in the absence of these proteins
(Figure 3C). In addition, LDH analysis revealed an Nlrp3-
dependent delay in cell death of BMDMs infected with V.
cholerae, again indicating that inflammasome-driven cell death
is taking place mainly at the early time points post V.
cholerae infection (Figure 3D). Finally, we used the specific
Nlrp3 inflammasome inhibitor MCC950 (31) to address
whether V. cholerae induced inflammasome responses could
be targeted in a pharmacological manner. Indeed, treatment
of WT macrophages with MCC950 decreased inflammasome-
dependent IL-1β secretion upon El Tor infection (Figure 3E).
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FIGURE 2 | Hemolysin is the main trigger for canonical inflammasome activation upon El Tor V. cholerae infection. (A) Bright field images of WT BMDMs infected with
different El Tor V. cholerae genotypes. (B–E) LPS-primed WT BMDMs were untreated (control) or infected with the indicated genotypes of V. cholerae (V.c.) at MOI50.
At 24 h post infection (B) cell culture supernatants were analyzed for secreted TNF and (C) IL-1β by ELISA (D) cell death was determined 6 and 24 h post infection by
LDH release assay. (E) Cell lysates at 24 h post infection were immunoblotted for IL-1β and caspase-1 maturation. Data shown in (B–D) are the means ± SD of
triplicate wells from a representative experiment out of three independent experiments. Data shown in (E) are representative for three independent experiments.
In addition, MCC950 diminished V. cholerae induced processing
of caspase-1 and IL-1β (Figure 3F) and it delayed lytic cell
death in macrophages infected with V. cholerae (Figure 3G).
Together with our prior observation that hlyA is the major
El Tor toxin triggering inflammasome responses, these genetic
and pharmacological experiments demonstrating that the El
Tor V. cholerae biotype activates the canonical Nlrp3/ASC
inflammasome suggest that hemolysin expressed by this
pathogen triggers canonical inflammasome activation via the
Nlrp3/ASC axis.
El Tor Vibrio cholerae Activates the Pyrin
Inflammasome in the Absence of
Hemolysin-Dependent Nlrp3 Activation
Our above experiments collectively indicated that hemolysin-
driven Nlrp3 activation was a dominant contributor to IL-1β
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FIGURE 3 | Maturation and secretion of IL-1β upon El Tor V. cholerae infection depends mainly on the Nlrp3 inflammasome. (A–D) LPS-primed BMDMs from mice
with indicated genotypes were untreated (control) or infected with V. cholerae (V.c.) at MOI50. At 24 h post infection (A) cell culture supernatants were analyzed for
secreted IL-1β and (B) TNF by ELISA, and (C) cell lysates of indicated BMDM genotypes were immunoblotted for IL-1β and caspase-1 maturation. (D) Cell death was
determined at 6 and 24 h post infection by LDH release assay. (E–G) LPS-primed BMDMs from WT mice were untreated or pre-treated with 10µM MCC950, as
indicated, and then untreated (control) or infected with V. cholerae (V.c.) at MOI50. At 24 h post infection (E) cell culture supernatants were analyzed for secreted IL-1β
by ELISA, and (F) cell lysates of indicated BMDM genotypes were immunoblotted for IL-1β and caspase-1 maturation. (G) Cell death was determined at 6 and 24 h
post infection by LDH release assay. Data shown in (A,B,D,E,G) are the means ± SD of triplicate wells from a representative experiment out of three independent
experiments. Data shown in (C,F) are representative for three independent experiments.
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processing upon El Tor V. cholerae infection. However, in the
absence of bacterial hlyA (Figure 2E) as well as upon blocking
host Nlrp3 activation (Figures 3C,F) we were able to detect
residual IL-1β maturation. Therefore, we speculated that El Tor
V. cholerae was capable of activating an additional hlyA/Nlrp3-
independent inflammasome. To identify this putative Nlrp3-
independent inflammasome, we took advantage of the MCC950
inhibitor to mitigate the dominant Nlrp3 effects and as such to
investigate the roles of other inflammasomes. Consistent with
our previous observations, MCC950-treated WT macrophages
secreted residual amounts of IL-1β upon V. cholerae infection
(Figure 4A). Interestingly however, while also MCC950-treated
Nlrc4- and Aim2-deficient macrophages still released IL-1β in
the culture medium upon El Tor V. cholerae infection, this
IL-1β secretion was abolished in similarly treated Pyrin−/−
macrophages (Figure 4A). In contrast, TNF was secreted
normally from MCC950-treated V. cholerae infected Pyrin−/−
macrophages (Figure 4B), demonstrating a still ongoing innate
immune response to the bacterium. Moreover, in the setting
of Nlrp3 inhibition by MCC950, western blotting analysis
showed residual caspase-1 and IL-1β maturation in WT but not
in Pyrin−/− macrophages upon El Tor V. cholerae infection
(Figure 4C). These observations indicated that El Tor V. cholerae
can activate the Pyrin inflammasome as a backup mechanism in
conditions of impaired Nlrp3 activation.
As a complementary approach to the above host genetic
experiments, we next used the V. cholerae mutant strains to
test whether the Pyrin inflammasome was also responsible
for the residual inflammasome responses observed in the
absence of both CT and hlyA. For this purpose, WT and
Pyrin−/− macrophages were infected with either WT V. cholerae
or with the 1ctxAB/hlyA mutant strain. Pyrin deficiency
as such only moderately reduced IL-1β secretion in WT
V. cholerae infected cells (Figure 4D), confirming that the
Nlrp3 inflammasome is dominant in mediating this response.
However, while the1ctxAB/hlyAmutant V. cholerae that cannot
activate Nlrp3 remained capable of inducing low levels of IL-
1β secretion from WT macrophages, Pyrin-deficient cells did
not display this 1ctxAB/hlyA-induced inflammasome response
(Figure 4D). Moreover, western blotting analysis showed that
the residual levels of processed caspase-1 and IL-1β as observed
in 1ctxAB/hlyA infected WT macrophages were diminished
in Pyrin−/− cells (Figure 4E). Together, while caspase-11-
independent activation of the canonical Nlrp3 inflammasome
by hemolysin appears the dominant mechanism toward IL-1β
secretion, our observations indicated that the El Tor V. cholerae
biotype can also activate the Pyrin inflammasome in the absence
of either host Nlrp3 or bacterial hemolysin expression.
DISCUSSION
El Tor V. cholerae is the causative biotype of the current cholera
pandemic (1, 3). While the Classical biotype driving the former
pandemics was characterized to exert its effects through CT,
the El Tor biotype expresses the accessory toxins hemolysin
and MARTX, both of which participate in host infection
alongside CT (32). To determine the contribution of El Tor
toxins to host innate defense mechanisms, we characterized the
inflammasome activation pathways and their bacterial triggers
during infection of murine macrophages with the N16961 El Tor
V. cholerae strain.
V. cholerae is generally regarded as one of the Gram-negative
enteropathogens that activates the non-canonical caspase-11-
dependent inflammasome, owing to its capacity of CT-mediated
LPS import in the cytosol. However, this prevailing notion stems
from infecting mouse macrophages with the Classical biotype
(20). In contrast, we report that the El Tor biotype of V.
cholerae induces normal inflammasome responses in caspase-11-
deficient murine macrophages. Furthermore, additional deletion
of caspase-1 abolished El TorV. cholerae induced IL-1β secretion,
showing that this biotype triggers canonical inflammasome
activation. Inflammasome responses induced by the El Tor
biotype did not rely on CT expression. Indeed, the lack of CT
expression in 1ctxAB mutants did not affect inflammasome
responses, while conversely boosting CT expression in the El
Tor biotype through specific in vitro culturing methods did not
augment inflammasome responses nor did it reveal a caspase-
11 dependency.
Given these clear observations that the El Tor biotype V.
cholerae induces a caspase-11- and CT-independent canonical
inflammasome activating pathway, it is conceivable that the
accessory toxins characteristic of this biotype are more efficient
in activating the inflammasome than the CTB-mediated cytosolic
delivery of LPS as observed in Classical V. cholerae strains.
Consistent with this idea, infections using1ctxAB/hlyAmutants
revealed a major contribution for the accessory toxin hemolysin
to inflammasome activation by the El Tor biotype V. cholerae.
Hemolysins are well-characterized pore-forming toxins and
are the main lethal toxins of El Tor V. cholerae strains in
murine studies (32, 33). Bacterial pore-forming toxins are known
to cause eﬄux of intracellular K+ ions, a common signal
sufficient for triggering Nlrp3-driven canonical inflammasome
activation (34). Indeed, in agreement with identifying the pore-
forming toxin hlyA as the bacterial instigator, genetic as well
as pharmacological experiments identified host Nlrp3 as the
main receptor responsible for initiating El Tor V. cholerae
induced canonical inflammasome activation and subsequent IL-
1β secretion.
Our observations showing that the El Tor V. cholerae
N16961 strain triggers the Nlrp3 inflammasome align with
a previous study showing that also the N86 El Tor strain
activates the Nlrp3 inflammasome (35). Although this study
used macrophages lacking both caspase-1 and caspase-11 and
therefore could not discriminate between the canonical and
non-canonical inflammasome pathways, their finding that also
in the N86 strain hlyA was largely responsible for caspase-1
activation (35) suggests that the hemolysin-induced canonical
Nlrp3 pathway observed in our study could be a general
inflammasome activating mechanism among El Tor biotype
strains. Interestingly, an hlyA-deficient El Tor N86 strain
displayed residual inflammasome activation that could be
abolished by additional deletion of the rtxA gene encoding the
MARTX accessory toxin (35). Although this led the authors
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FIGURE 4 | El Tor V. cholerae infection activates the Pyrin inflammasome in an Nlrp3- and hlyA-independent manner. (A–C) LPS-primed BMDMs from mice with
indicated genotypes were left untreated or pre-treated with 10µM MCC950 to block Nlrp3 activation, as indicated, and then untreated (control) or infected with V.
cholerae (V.c.) at MOI50. At 24 h post infection (A) Cell culture supernatants were analyzed for secreted IL-1β and (B) TNF by ELISA, and (C) cell lysates of WT and
Pyrin−/− BMDMs were immunoblotted for IL-1β and caspase-1 maturation. (D,E) LPS-primed BMDMs from WT and Pyrin−/− mice were untreated (control) or
infected with V. cholerae (V.c.) with indicated genotypes at MOI50. At 24 h post infection (D) Cell culture supernatants were analyzed for secreted IL-1β by ELISA, and
(E) cell lysates were immunoblotted for IL-1β and caspase-1 maturation. Data shown in (A,B,D) are the means ± SD of triplicate wells (A,B) from a single experiment,
or (D) from a representative out of three independent experiments. Data shown in (C,E) are representative for three independent experiments.
to speculate about mechanisms through which MARTX could
potentially contribute to Nlrp3 inflammasome activation (35),
our observations suggest that MARTX might instead trigger
an Nlrp3-independent inflammasome. Indeed, similar to the
hlyA-deficient N86 El Tor strain, we observed residual IL-
1β maturation and secretion induced by 1ctxAB/hlyA N16961
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El Tor mutants. These inflammasome responses were lost in
Pyrin−/− macrophages, suggesting that the N16961 El Tor
strain could trigger an Nlrp3-independent Pyrin inflammasome
pathway. In line with this notion, Nlrp3 inhibition with MCC950
was only able to fully block V. cholerae induced IL-1βmaturation
and secretion in Pyrin-deficient conditions. These observations
indicated that Pyrin activation constitutes an additional hlyA-
and Nlrp3-independent driver of inflammasome responses to El
Tor V. cholerae infection. Interestingly, the El Tor characteristic
MARTX is capable of inactivating host Rho GTPases (36),
which in the context of several other bacteria was shown to be
the cytoskeletal damage induced event that activates the Pyrin
inflammasome (19). Therefore, it is tempting to speculate that
the observed Nlrp3- and hlyA-independent Pyrin inflammasome
activation was induced by the MARTX El Tor accessory toxin.
Such a pro-inflammatory role for the MARTX toxin would be in
line with its known contribution to El Tor V. cholerae induced
lethality as well as inflammation in mice (32, 37). Alternatively, a
recent study showed that recombinant CTB can act as a Pyrin
activator in LPS-stimulated murine peritoneal macrophages
(38). However, since we show that a V. cholerae 1ctxAB/hlyA
mutant still activates Pyrin-dependent IL-1β secretion in murine
BMDMs, CTB clearly is dispensable for Pyrin activation in
bone marrow derived macrophages. This finding aligns with
the observation that recombinant CTB activated the Pyrin
inflammasome in peritoneal but not in bone marrow derived
macrophages (38), and thus indicates thatV. choleraemay engage
different inflammasome activation mechanisms in a cell-type
specific manner.
Our study demonstrating the importance of the differential
toxin expression repertoire in Classical vs. El Tor V. cholerae
biotypes for triggering inflammasome responses may explain
previous observations in a human cell line. Indeed, although not
pinpointing the activation of either canonical or non-canonical
inflammasomes, a study using human THP-1 monocytes found
that El Tor V. cholerae biotypes were more potent inflammasome
activators when compared to Classical biotypes (13). However,
in contrast to our observations revealing both hlyA-dependent
and -independent modes of inflammasome activation in murine
macrophages, IL-1β maturation in El Tor infected THP-1 cells
depended entirely on hlyA (13), suggesting that El Tor V.
cholerae does not activate the Pyrin inflammasome in the human
THP-1 cell line. However, given the differential capacity of El
Tor V. cholerae to trigger Pyrin inflammasome activation in
bone marrow derived vs. peritoneal macrophages in mice (38),
it remains possible that other human myeloid cell types are
susceptible to this trait of the El Tor biotype.
Thus, our study shows that the El Tor V. cholerae N16961
strain utilizes distinct accessory toxins to drive caspase-11- and
CT-independent canonical inflammasome activation through
Nlrp3- and Pyrin-dependent mechanisms. While their relative
contributions to pathology remain to be investigated, our study
suggests that the El Tor V. cholerae biotype that drives the
current seventh cholera pandemic (1, 3) may trigger parallel
Nlrp3- and Pyrin-dependent pathways to induce secretion of
inflammasome-dependent pro-inflammatory cytokines.
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